In this article we review the commonest cause of neurogenic arthrogryposis, termed Spinal Muscular Atrophy Lower Extremity Dominant (SMALED), due to variants in DYNC1H1 and BICD2. We discuss the characteristic clinical and radiological phenotype of this disorder and how this has facilitated the identification of the genetic cause of SMALED2. We also review the similarities and differences between the human SMALED phenotype and mouse models and how this has informed our understanding of the potential mechanisms governing motor neuron loss in these disorders.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.nmd.2021.07.399 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- Neurogenetic disorders linked to mutations in spectrin genes lead to a wide range of symptoms, from peripheral nervous system issues to complex syndromes, emphasizing their diverse impact.
- An international study identified 14 families with unexplained distal weakness due to heterozygous loss-of-function variants, collecting standardized clinical and imaging data to analyze the condition further.
- The research found that all 20 patients exhibited early childhood onset of distal weakness with varying severity, along with associated foot abnormalities and muscle changes, confirming the link between these genetic variants and a new syndrome characterized by primarily myogenic effects.
A Case Report: Can Prioritizing Sensory Integration Therapy Help Improve Gross Motor Function in a Rare Case of Neurogenic Arthrogryposis Multiplex Congenita?
Cureus
February 2024
Physical Medicine and Rehabilitation, The South Indian Association (SIA) College of Health Sciences, College of Physiotherapy, Thane, IND.
Arthrogryposis multiplex congenital (AMC) is a congenital disorder diagnosed with extremity contractures, restricted joint range of motion, foot abnormalities, and hip dislocation. The current literature emphasizes medical and surgical management, but very few studies provide insight into physiotherapy management for AMC. We reported the case of a 16-month-old male diagnosed with AMC, operated on both hips for teratologic dislocation.
View Article and Find Full Text PDFDST variants are responsible for neurogenic arthrogryposis multiplex congenita enlarging the spectrum of type VI hereditary sensory autonomic neuropathy.
Clin Genet
November 2023
Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-1195, Université Paris Saclay, Le Kremlin Bicêtre, France.
Article Synopsis
- Arthrogryposis multiplex congenita (AMC) is a condition that happens when babies can't move their joints much before they are born.
- Scientists studied a baby with AMC and found two problems in a gene called Dystonin (DST) that affects nerves.
- These gene problems can cause nerve issues in families, and the study helps us understand more about how AMC happens.
Diagnostic work-up and phenotypic characteristics of a family with variable severity of distal arthrogryposis type 2B (Sheldon-Hall syndrome) and TNNT3 pathogenic variant.
Front Genet
March 2023
AnDDI-RARE Paris Referral Center for Birth Defects, Division of Medical Genetics, APHP Paris Saclay University, Paris, France.
Article Synopsis
- Sheldon-Hall syndrome (SHS), also known as distal arthrogryposis 2B (DA2B), is a rare condition marked by joint contractures and mild facial abnormalities, linked to mutations in specific muscle-related genes.
- A 16-year-old boy with severe kyphoscoliosis and respiratory issues, along with family members exhibiting milder symptoms, underwent a thorough diagnostic process that included physical exams, MRI, and genetic testing.
- Findings revealed a significant TNNT3 gene mutation in the boy, marking the first reported instance of neurogenic features in a DA2B patient, prompting questions about how developmental issues in fetal life might influence these symptoms and the role of genetic factors in SHS.
Early onset hereditary neuronopathies: an update on non-5q motor neuron diseases.
Brain
March 2023
Neuromuscular Repair Unit, Institute of Experimental Neurology (InSpe), Division of Neuroscience, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Hereditary motor neuropathies (HMN) were first defined as a group of neuromuscular disorders characterized by lower motor neuron dysfunction, slowly progressive length-dependent distal muscle weakness and atrophy, without sensory involvement. Their cumulative estimated prevalence is 2.14/100 000 and, to date, around 30 causative genes have been identified with autosomal dominant, recessive,and X-linked inheritance.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!